HALO logo

Halozyme Therapeutics, Inc. (HALO) Short term debt

Annual short term debt:

N/A
December 31, 2024

Summary

  • HALO annual short term debt is not available.

Performance

HALO Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherHALObalance sheet metrics

quarterly short term debt:

N/A
March 31, 2025

Summary

  • HALO quarterly short term debt is not available.

Performance

HALO quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherHALObalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

HALO Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

HALO Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

HALO Short term debt History

DateAnnualQuarterly
Dec 2022
$13.33M(-85.1%)
$13.33M(+0.1%)
Sep 2022
-
$13.31M(-86.6%)
Jun 2022
-
$99.05M(+10.6%)
Mar 2022
-
$89.55M(+0.1%)
Dec 2021
$89.42M(-77.5%)
$89.42M(+0.2%)
Sep 2021
-
$89.25M(+0.1%)
Jun 2021
-
$89.17M(+0.1%)
Mar 2021
-
$89.04M(-77.6%)
Dec 2020
$397.23M(+1932.7%)
$397.23M(>+9900.0%)
Mar 2020
-
$2.86M(-85.4%)
Dec 2019
$19.54M(-78.6%)
$19.54M(-64.2%)
Sep 2019
-
$54.54M(-23.1%)
Jun 2019
-
$70.88M(-18.2%)
Mar 2019
-
$86.66M(-5.3%)
Dec 2018
$91.51M(+18.5%)
$91.51M(+3.4%)
Sep 2018
-
$88.52M(+1.8%)
Jun 2018
-
$86.97M(+5.5%)
Mar 2018
-
$82.46M(+6.8%)
DateAnnualQuarterly
Dec 2017
$77.21M(+343.9%)
$77.21M(+25.7%)
Sep 2017
-
$61.43M(+35.0%)
Jun 2017
-
$45.52M(+53.8%)
Mar 2017
-
$29.60M(+70.2%)
Dec 2016
$17.39M(-20.4%)
$17.39M(+40.3%)
Sep 2016
-
$12.39M(+276.9%)
Jun 2016
-
$3.29M(-88.0%)
Mar 2016
-
$27.42M(+25.4%)
Dec 2015
$21.86M
$21.86M(+39.3%)
Sep 2015
-
$15.70M(+62.6%)
Jun 2015
-
$9.66M(+158.9%)
Mar 2015
-
$3.73M(-63.0%)
Sep 2014
-
$10.07M(+62.4%)
Jun 2014
-
$6.20M(+158.0%)
Mar 2014
-
$2.40M(-59.7%)
Sep 2013
-
$5.97M(+63.9%)
Jun 2013
-
$3.64M(+167.5%)
Mar 2013
-
$1.36M

FAQ

  • What is the all time high annual short term debt for Halozyme Therapeutics, Inc.?
  • What is the all time high quarterly short term debt for Halozyme Therapeutics, Inc.?

What is the all time high annual short term debt for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual short term debt is $397.23M

What is the all time high quarterly short term debt for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly short term debt is $397.23M
On this page